First-of-its-kind Parkinson’s biomarker guidelines invigorates drive for treatments: Creating guidelines for discovering Parkinson’s biomarkers is key to developing treatments

Parkinson’s disease affects more than 4 million people worldwide, with numbers projected to double in the next few decades. With